Maprotiline
Maprotiline
Maprotiline (pronounced: ma-pro-ty-leen) is a tetracyclic antidepressant used in the treatment of depression and anxiety disorders. It is also known by its brand names, Ludiomil and Deprilept.
Etymology
The term "Maprotiline" is derived from its chemical structure, which is a maprotiline molecule. The prefix "mapro-" is derived from the Greek word "mapro", meaning "long", and the suffix "-tiline" is a common ending for tetracyclic antidepressants.
Usage
Maprotiline is used primarily to treat major depressive disorder (MDD), anxiety disorders, and, in some cases, neuropathic pain. It works by inhibiting the reuptake of norepinephrine and, to a lesser extent, serotonin, thereby increasing the levels of these neurotransmitters in the brain.
Side Effects
Common side effects of Maprotiline include drowsiness, dizziness, dry mouth, constipation, and blurred vision. In rare cases, it can cause cardiac arrhythmia, seizures, and suicidal ideation.
Related Terms
- Tetracyclic antidepressant
- Depression
- Anxiety disorders
- Major depressive disorder
- Norepinephrine
- Serotonin
- Neuropathic pain
See Also
External links
- Medical encyclopedia article on Maprotiline
- Wikipedia's article - Maprotiline
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski